Henan Newland Pharmaceutical Co. Ltd. A (301277) — Free Cash Flow Generation Index
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Free Cash Flow Generation Index of 0.13x as of December 2025. Free cash flow of CN¥15.55 Million represents 0% of operating cash flow (CN¥116.94 Million). Read 301277 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. Explore Henan Newland Pharmaceutical Co. Ltd. A (301277) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year Free Cash Flow Generation Index for Henan Newland Pharmaceutical Co. Ltd. A. For the full company profile including market capitalisation, see how much is Henan Newland Pharmaceutical Co. Ltd. A worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥15.55 Million | CN¥116.94 Million | CN¥101.38 Million | ▲ +5.6% |
| 2024 | 0.13x | CN¥15.97 Million | CN¥126.76 Million | CN¥110.79 Million | ▼ -79.9% |
| 2023 | 0.63x | CN¥162.94 Million | CN¥259.46 Million | CN¥96.51 Million | ▲ +511.9% |
| 2022 | 0.10x | CN¥8.50 Million | CN¥82.85 Million | CN¥74.34 Million | ▼ -78.7% |
| 2021 | 0.48x | CN¥23.68 Million | CN¥49.08 Million | CN¥25.40 Million | ▼ -25.3% |
| 2020 | 0.65x | CN¥30.90 Million | CN¥47.86 Million | CN¥16.96 Million | — |